Ann: Response to ASX Price Query , page-33

MEDIGEN: SP $9.75; MC $1.35 bill; Shares 138.7 mill (AUD).

Based in Taiwan.
SP appreciated around 35% in past two weeks.
PI-88 if successful will be a big drug for them.
Hepatocellular carcinoma estimated worldwide market over 2 bill (2015).
PI-88 trial (PATRON) due to finish 1H 2015 (?).

PROGEN:

Share of PI-88: 4 milestone payments (2 already received?).
Low double digit royalty on sales.
Pharmasynth: : Wholly owned drug manufacturing facility currently supplying PI-88 for PATRON trial plus other small contracts. Will it supply PI-88 if successful?
PG545: Treatment for advanced solid tumors in cancer patients currently in Phase I (safety and tolerability) after promising pre- clinical trials.
Cash on hand: $6.5 mill (31/12/2013); Cash burn $2 mill per 6 months.

A bit jumbled I know. What is it worth now? What will it be worth 2015 if PI-88 successful? Any ideas from people smarter than me who can dig a bit.

Certainly a bit of interest atm. Not traders yet? Has it reached an intermediate top yet? Could drop like a rock. Who knows?

Me, I am in at 25c and am holding for the fundamentals unless somebody /something changes my mind.